Concepedia

Melissa Ooi

MO

20

Publications

946

Citations

16

H-Index

2006

Active since

Affiliations

National University Cancer Institute, Singapore(Current)

Dana-Farber Cancer Institute

Harvard University

National University Health System

National University of Singapore

Melissa Ooi is an author at National University Cancer Institute, Singapore specializing in oncology, medicine, and cancer research.

ORCID

Top concepts

Publications per year

2006–2024

20

Publications

20

Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications

Jana Jakubı́ková, Sophia Adamia, Maria Kost‐Alimova et al. · Blood · 2011 · 153 citations · Full text

Antimyeloma Activity of the Orally Bioavailable Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235

Douglas W. McMillin, Melissa Ooi, Jake Delmore et al. · Cancer Research · 2009 · 122 citations

Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis

Phaik Ju Teoh, Ömer An, Tae‐Hoon Chung et al. · Blood · 2018 · 103 citations · Full text

Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma

David Cervi, Melissa Ooi, Saifun Nahar et al. · Haematologica · 2011 · 73 citations · Full text

Interactions of the Hdm2/p53 and Proteasome Pathways May Enhance the Antitumor Activity of Bortezomib

Melissa Ooi, Patrick Hayden, Vassiliki Kotoula et al. · Clinical Cancer Research · 2009 · 70 citations · Full text

Rows per page

1–5 of 20